EarlySense secures $39M for patient monitoring solutions
The majority of the funding came from hospital bed manufacturer Hill-Rom and Wells Fargo Strategic Capital, the venture capital and growth equity investment arm of Wells Fargo & Company.
Report projects passive monitoring tech adoption will shape post-acute care facility landscape
A new Frost and Sullivan report suggests that post-acute care facilities could strengthen their positions in an increasingly competitive landscape by integrating continuous monitoring technology and improving the outcome of high acuity patients.
EarlySense raises $25M in expansion of remote patient monitoring sensors from hospital to home
EarlySense CEO Avner Halperin said the funding will be used to accelerate our commercial growth in the hospital/ nursing home market.
EarlySense gets FDA device approval for patient monitor update with benchmarking tool
Medical device maker EarlySense has received a green light for an updated version of its FDA-approved patient monitoring device. The tool uses a pad-sized sensor that fits under the mattress to transmit data on respiration and heart rate as well as movement to a bedside monitor and a monitor at a nurse station. The updated […]
Israeli medical device firm EarlySense makes Massachusetts its HQ
EarlySense Ltd. announced its intentions to open its U.S. headquarters in Massachusetts. The move is a “direct result” of Mass. Gov. Deval Patrick’s March trip to Israel, where he met with EarlySense officials, according to a Mass. Life Sciences Center official. “He convinced us that Massachusetts would be the best location to run our national […]
EarlySense raises $7M for patient monitoring system
EarlySense has raised $7 million in investment funding to continue commercializing its patient monitoring system for hospitals, bringing its fundraising for the year to an impressive $20 million.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
EarlySense gets FDA nod for central display of patient data
Israeli medical device company EarlySense Ltd. announced today that its EverOn Central Display Station -- which accompanies its EverOn Touch patient monitoring system -- has been cleared for marketing in the United States by the Food and Drug Administration.
EarlySense gets FDA nod for improved patient-monitoring system
Updated 12:20 p.m., June 22, 2010. Israeli medical device company EarlySense Ltd., which recently closed a $13 million fundraising round, has received Food and Drug Administration (FDA) clearance to sell its EverOn Touch patient-monitoring system in the United States. The company based in Ramat Gan, Israel, also is pursuing European market clearance for the enhanced […]
Israel’s EarlySense gets $13M to launch patient monitoring system
Updated 6:59 p.m. Israeli device company EarlySense has raised $13 million from investors to launch its EverOn patient monitoring system in the United States and Europe. The company based in Ramat Gan, Israel last year received a grant from the Global Cardiovascular Innovation Center led by the Cleveland Clinic. At that time, EarlySense said it […]
Israeli firm EarlySense moving to Cleveland, developing new heart-monitoring application
EarlySense, which monitors a series of vital signs in hospitals and home health care settings, is among four companies that will share $2 million in grants from the Global Cardiovascular Innovation Center (GCIC).
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
An early sense on an Israeli device business that could come to Ohio
Greater Cleveland likes promising Israeli medical companies. The next best opportunity for Cleveland to grab an Israeli company is probably EarlySense, which has created a monitoring system for hospitals and home health care settings. All it may take are investors and customers.